ETFChannel.com
NEO Description — NeoGenomics Inc

NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope.

Company Name: 
NeoGenomics Inc
Website: 
www.neogenomics.com
Sector: 
Diagnostics
Number of ETFs Holding NEO: 
44
Total Market Value Held by ETFs: 
$1,245,253,591.75
Total Market Capitalization: 
$5,794,000,000
% of Market Cap. Held by ETFs: 
21.49%
 ETF   NEO Weight   NEO Amount 
 IJR   0.55%   $377,895,746         
 VTI   0.01%   $152,384,222         
 VB   0.10%   $133,706,623         
 IWM   0.19%   $123,200,668         
 VBK   0.22%   $84,723,508         
 VXF   0.07%   $80,792,403         
 IJT   1.17%   $73,390,177         
 IWO   0.36%   $43,650,072         
 SLYG   1.17%   $27,732,088         
 PSCH   4.60%   $23,297,410         
List of all 44 ETFs holding NEO »
Quotes delayed 20 minutes

Strong Buy (3.61 out of 4)
57th percentile
(ranked higher than approx. 57% of all stocks covered)

Analysts Forecast:
NEO Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding NEO | NeoGenomics Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.